Claybrook Capital’s LeMaitre Vascular LMAT Stock Holding History

Claybrook Capital’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-114	Closed	-$3K	–	422
2018 Q4	$3K	Buy	+114	New	+$3.11K	﹤0.01%	613

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Claybrook Capital's LMAT Position: Q1 2019 in Review

Claybrook Capital sold out of LeMaitre Vascular (LMAT) in Q1 2019, closing a stake of 114 shares — an estimated $3K sold.

Claybrook Capital first reported a position in LMAT in Q4 2018 and held it in 1 quarter. The position peaked at $3K in Q4 2018. 155 funds tracked by Wall St. Rank hold LMAT as of Q1 2019.

Claybrook Capital reported no remaining LeMaitre Vascular position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 114 LeMaitre Vascular shares in Q1 2019, an estimated $3K.
Claybrook Capital first reported a position in LeMaitre Vascular in Q4 2018 and held it in 1 quarter.
Claybrook Capital's LeMaitre Vascular position peaked at $3K in Q4 2018.
155 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.